NCT06994689 Clinimetric Properties of Muscle Mass and Stiffness Measurements of the Quadriceps in Patients With COPD
| NCT ID | NCT06994689 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Groupe Hospitalier du Havre |
| Condition | COPD |
| Study Type | OBSERVATIONAL |
| Enrollment | 30 participants |
| Start Date | 2025-05-30 |
| Primary Completion | 2026-10-01 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
This is an observational study. You will not receive an experimental treatment; researchers will collect data based on your existing condition or standard treatment.
This trial targets 30 participants in total. It began in 2025-05-30 with a primary completion date of 2026-10-01.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
A large amount of patients with COPD suffer from muscle dysfunction characterized by losses of muscle mass and strength. Studies have shown an association between a loss of quadriceps muscle mass and premature death. This study aims to investigate the clinimetric properties of a simple quadriceps perimetry and ShearWave elastography to improve the monitoring of skeletal muscle function in patients with COPD.
Eligibility Criteria
Inclusion Criteria: * COPD patients * Adults (\>18 years old) * Patients starting a pulmonary rehabilitation (PR) programme Exclusion Criteria: * Patients included in other research protocol * Minors or under guardianship * Pregnancy * Patients with lower limb amputation or history of neuromuscular disease * Cardiovascular contradications for PR
Contact & Investigator
Frequently Asked Questions
Who can join the NCT06994689 clinical trial?
This trial is open to participants of all sexes, aged 18 Years or older, studying COPD. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT06994689 currently recruiting?
Yes, NCT06994689 is actively recruiting participants. Contact the research team at claire.dubois@ch-havre.fr for enrollment information.
Where is the NCT06994689 trial being conducted?
This trial is being conducted at Le Havre, France.
Who is sponsoring the NCT06994689 clinical trial?
NCT06994689 is sponsored by Groupe Hospitalier du Havre. The trial plans to enroll 30 participants.
Related Trials
Related Intelligence Guides
In-depth guides covering this condition's trials, eligibility, and what to expect.